Gail Marcus Biography and Net Worth

Director of Natera


Gail Marcus has served as a member of our board of directors since March 2017. Dr. Marcus is currently an Assistant Professor and Executive in Residence at the Massachusetts College of Pharmacy and Health Sciences. Prior to academia, Dr. Marcus was a healthcare executive across a diverse portfolio of healthcare organizations in the US and UK, including Cigna, UnitedHealthcare Group Inc., CVS/Caremark, and Caris Diagnostics of Caris Life Sciences. In 2014, she was selected as one of the top 100 women executives in Massachusetts. Dr. Marcus currently serves on the boards of directors of another public company, a private company and a non-profit organization, and sits on the Centers for Medicare & Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests. Dr. Marcus holds aDoctorate of Health Administration from the Medical University of South Carolina.  She received a B.A. in Spanish and Mathematics from Wesleyan University, an M.S.E. in Computer and Information Sciences from the University of Pennsylvania Moore School Of Engineering and a M.B.A. from the Wharton School of the University of Pennsylvania. 

What is Gail Boxer Marcus' net worth?

The estimated net worth of Gail Boxer Marcus is at least $524,628.00 as of November 20th, 2020. Dr. Marcus owns 11,400 shares of Natera stock worth more than $524,628 as of February 7th. This net worth evaluation does not reflect any other assets that Dr. Marcus may own. Learn More about Gail Boxer Marcus' net worth.

How do I contact Gail Boxer Marcus?

The corporate mailing address for Dr. Marcus and other Natera executives is 201 INDUSTRIAL ROAD SUITE 410, SAN CARLOS CA, 94070. Natera can also be reached via phone at (650) 249-9090 and via email at [email protected] Learn More on Gail Boxer Marcus' contact information.

Has Gail Boxer Marcus been buying or selling shares of Natera?

Gail Boxer Marcus has not been actively trading shares of Natera in the last ninety days. Most recently, Gail Boxer Marcus sold 19,169 shares of the business's stock in a transaction on Friday, November 20th. The shares were sold at an average price of $85.29, for a transaction totalling $1,634,924.01. Following the completion of the sale, the director now directly owns 11,400 shares of the company's stock, valued at $972,306. Learn More on Gail Boxer Marcus' trading history.

Who are Natera's active insiders?

Natera's insider roster includes Roy Baynes (Director), Roelof Botha (Director), Michael Brophy (CFO), Rowan Chapman (Director), Steven Chapman (CEO), Todd Cozzens (Director), James Healy (Director), Gail Marcus (Director), Daniel Rabinowitz (Insider), Matthew Rabinowitz (Chairman), Herm Rosenman (Director), Robert Schueren (COO), and Jonathan Sheena (Insider). Learn More on Natera's active insiders.

Are insiders buying or selling shares of Natera?

During the last twelve months, Natera insiders bought shares 2 times. They purchased a total of 372,820 shares worth more than $11,323,786.80. During the last twelve months, insiders at the medical research company sold shares 62 times. They sold a total of 164,110 shares worth more than $6,807,068.72. The most recent insider tranaction occured on February, 1st when CFO Michael Burkes Brophy sold 19,326 shares worth more than $844,159.68. Insiders at Natera own 10.3% of the company. Learn More about insider trades at Natera.

Information on this page was last updated on 2/1/2023.

Gail Boxer Marcus Insider Trading History at Natera

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2020Sell19,169$85.29$1,634,924.0111,400View SEC Filing Icon  
5/18/2020Sell7,278$45.99$334,715.22497View SEC Filing Icon  
See Full Table

Gail Boxer Marcus Buying and Selling Activity at Natera

This chart shows Gail Boxer Marcus's buying and selling at Natera by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Natera Company Overview

Natera logo
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Read More

Today's Range

Now: $46.02
Low: $42.84
High: $46.06

50 Day Range

MA: $40.83
Low: $36.57
High: $46.55

2 Week Range

Now: $46.02
Low: $26.10
High: $74.82

Volume

911,186 shs

Average Volume

1,343,895 shs

Market Capitalization

$4.49 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26